litigation
confidence high
sentiment positive
materiality 0.80
Prime Medicine wins arbitration against Beam; PM647 for AATD confirmed within Prime's field
Prime Medicine, Inc.
- Arbitration tribunal ruled PM647 (AATD candidate) is within Prime's 'Field' under 2019 Collaboration Agreement with Beam.
- Tribunal denied Beam's claims for damages and injunctive relief; Prime did not breach agreement.
- Remaining claims from both parties were denied.
- This removes legal overhang on Prime's AATD program.